![Christine Roth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Roth
Directeur/Membre du Conseil chez
FARON PHARMACEUTICALS OY
Fortune : 25 325 $ au 31/08/2026
Profil
Christine Roth currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2023.
Ms. Roth also formerly worked at Bayer AG, as Executive VP-Oncology Strategic Business from 2022 to 2024.
Ms. Roth received her undergraduate degree from the University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 48 022 ( 0,02% ) | 25 325 $ | 31/08/2026 |
Postes actifs de Christine Roth
| Sociétés | Poste | Début |
|---|---|---|
| FARON PHARMACEUTICALS OY | Directeur/Membre du Conseil | 22/09/2023 |
Anciens postes connus de Christine Roth
| Sociétés | Poste | Fin |
|---|---|---|
| BAYER AG | Corporate Officer/Principal | 01/01/2024 |
Formation de Christine Roth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
